A Comprehensive Pharmacognostical and Pharmacological Overview of Mimosa Pudica Linn
Keywords:
Mimosa pudica Linn, pharmacognosy, phytochemistry, pharmacological activities, Ayurveda, touch-me-not plantAbstract
Mimosa pudica Linn., commonly known as the “touch-me-not” plant, is a perennial creeping herb belonging to the family Fabaceae, noted for its rapid seismonastic movement upon tactile stimulation. It holds a significant place in traditional medical systems such as Ayurveda, Siddha, and Unani, where it is used for a wide range of ailments. The plant is widely distributed across tropical and subtropical regions. Pharmacognostically, it is distinguished by its bipinnate sensitive leaves, pink globose inflorescences, and prickly stems. Microscopic evaluation reveals diagnostic features such as paracytic stomata, unicellular trichomes, and prismatic calcium oxalate crystals. Phytochemical analyses have identified diverse bioactive constituents including alkaloids, flavonoids, tannins, glycosides, saponins, terpenoids, and phenolic compounds, which contribute to its pharmacological versatility.Modern pharmacological studies substantiate its wide therapeutic profile, demonstrating antimicrobial, anti-inflammatory, antidiabetic, antivenom, wound-healing, hepatoprotective, antioxidant, antiulcer, and antidepressant activities. Many of these effects correlate with its traditional uses, such as in treating wounds, urinary disorders, and inflammatory conditions. Furthermore, emerging experimental data suggest potential roles in neuroprotection and cancer chemoprevention, although clinical evidence remains limited.This review aims to integrate classical knowledge with contemporary pharmacological findings, providing a consolidated understanding of M. pudica. Special emphasis is placed on its botanical description, pharmacognostic parameters, phytochemical constituents, and experimentally validated pharmacological activities. Existing research gaps, particularly in the areas of compound isolation, clinical trials, and formulation standardization, are highlighted to guide future drug development
Downloads
Metrics
References
Sharma PV. Dravyaguna Vijnana. Vol II. Varanasi: Chaukhambha Bharati Academy; 2006. p. 432-4.
Mabberley DJ. The Plant Book. 2nd ed. Cambridge: Cambridge University Press; 1997.
Kirtikar KR, Basu BD. Indian Medicinal Plants. 2nd ed. Dehradun: International Book Distributors; 2003. p. 911-3.
Holm L, Plucknett DL, Pancho JV, Herberger JP. The World’s Worst Weeds. Honolulu: University Press of Hawaii; 1977. p. 153-5.
Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy. 50th ed. Pune: Nirali Prakashan; 2014.
Kanchanapoom T, Chumsri P, Kasai R, Otsuka H. C-glycosylflavones from Mimosa pudica. Phytochemistry. 2001;57(8):1223-6.
Anitha R, Jayakumari S. Phytochemical screening of Mimosa pudica Linn. Int J Pharm Sci Rev Res. 2014;29(2):41-3.
Pari L, Latha M. Antidiabetic activity of Mimosa pudica Linn. in rats. J Ethnopharmacol. 2002;83(1-2):43-50.
Singh A, Singh PK. Pharmacological evaluation of Mimosa pudica Linn. Indian J Pharmacol. 2012;44(2):197-202.
Rajendran R, Krishnakumar E. Antimicrobial activity of Mimosa pudica root extract. Asian J Pharm Clin Res. 2010;3(4):89-91.
Gupta S, Bansal P. Anti-inflammatory and analgesic potential of Mimosa pudica. Pharm Biol. 2013;51(12):1521-7.
Latha M, Pari L. Hypoglycemic effect of Mimosa pudica Linn. J Ethnopharmacol. 2004;90(2-3):217-20.
Akinmoladun FO, Komolafe TR. Antioxidant profile of Mimosa pudica. J Med Plants Res. 2015;9(8):288-94.
Shetty S, Udupa SL. Wound healing effect of Mimosa pudica. Fitoterapia. 2009;80(7):522-4.
Choudhary M, Kumar V. Hepatoprotective potential of Mimosa pudica. J Ayurveda Integr Med. 2014;5(3):150-6.
Dhawan K, Kumar S. Antidepressant activity of Mimosa pudica. Indian J Exp Biol. 2001;39(2):108-12.
Udayakumar R, Sokkalingam A. Antiulcer properties of Mimosa pudica. Pharmacologyonline. 2009;3:220-7.
Gomes A, et al. Antivenom potential of Mimosa pudica. J Ethnopharmacol. 2007;111(2):362-7.
Murthy KRS. Bhavaprakasha of Bhavamishra. Varanasi: Chaukhambha Krishnadas Academy; 2008.
OECD. Acute Oral Toxicity – Guideline 425. Paris: OECD Publishing; 2008.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.